[This corrects the article on p. 486 in vol. 7, PMID: 28018223.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360727 | PMC |
| http://dx.doi.org/10.3389/fphar.2017.00152 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "Illudin S inhibits p53-Mdm2 interaction for anticancer efficacy in colorectal cancer" [Biomed. Pharmacother. 182 (2025) 117795].
Biomed Pharmacother
January 2025
Department of Chemistry, Sungkyunkwan University, Suwon 16419, Republic of Korea. Electronic address:
Corrigendum to "Mechanism of Gastrodin against neurotoxicity based on network pharmacology, molecular docking and experimental verification" [Biomed. Pharmacother. 180 (2024) 117611].
Biomed Pharmacother
January 2025
Department of Pharmacology of Chinese Materia Medica, Institution of Chinese Integrative Medicine, Hebei Medical University, Shijiazhuang, Hebei Province 050017, China. Electronic address:
[Not Available].
Ann Cardiol Angeiol (Paris)
January 2025
Université Caen Normandie, Medical School, UNICAEN, INSERM U1086 ANTICIPE, Normandie Univ, 14000, Caen, France; Sapienza University of Rome, Department of Cardiovascular, Respiratory, Nephrological, Anesthesiological and Geriatric Sciences, Rome, Italy.
Corrigendum to "Alginate/gum arabic-based biomimetic hydrogel enriched with immobilized nerve growth factor and carnosine improves diabetic wound regeneration" [Carbohydrate Polymers 321, (2023), 121179].
Carbohydr Polym
March 2025
Department of Pharmaceutical Biomaterials and Medical Biomaterial Research Center (MBRC), Faculty of Pharmacy, Tehran University of Medical Science, Tehran, Iran; Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Biomaterials Group, Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Science, Tehran, Iran. Electronic address:
Corrigendum to "Patient tissue-derived FGFR4-variant and wild-type colorectal cancer organoid development and anticancer drug sensitivity testing" [Heliyon Vol 10, Iss 10, May 2024, Article e30985].
Heliyon
December 2024
Department of Pharmacy, The Second Affiliated Hospital, Shantou University Medical College, Shantou, 515041, Guangdong, China.
[This corrects the article DOI: 10.1016/j.heliyon.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!